for example, owing to adverse effects, patient preference, cost pressures or formulary decisions
Graphical Abstract INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by excessive fat build up in the liver, with a global prevalence of 25% [1,2]
Texas Medical Association
The PET images show, for the first time in human, glucagon expression in the liver (left) and GLP-1 expression in the pancreas (right) in a patient with type 2 diabetes
The proper use of carnitine does show advantages at the end of the race season, especially for the birds that go to the medium distance 350-550 km every weekend or the long distance races and the long young bird races
BPC-157 remains unapproved for human use, as large-scale clinical trials confirming its safety and efficacy are still absent, according to the Food and Drug Administration (FDA)